Status:
RECRUITING
Adaptation of the ECCCLORE Program for Patients With Addictive and Traumatic Problems
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
PTSD
Addiction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Complex posttraumatic stress disorder (cPTSD) is characterized by chronic and pervasive disruptions in emotion regulation, identity, and relationships following prolonged or multiple exposures to trau...
Eligibility Criteria
Inclusion Criteria:
- Patients with one or more addictions
- ASSIST questionnaire score greater than or equal to 11 for alcohol consumption and greater than or equal to 4 for other substances.
- Diagnosis of PTSD and/or CPTSD assessed using the ITQ scale.
- Ability to understand, write, and read French
- The patient must have given their free and informed consent
- The patient must be a member or beneficiary of a health insurance plan
Exclusion Criteria:
- The subject is participating in an interventional study involving a drug or medical device or a Category 1 study within 3 months prior to inclusion
- The patient is under safeguard of justice or state guardianship
- Patients with a psychotic disorder
- Patients with severe cognitive impairment (MoCA < 10)
- Patients experiencing a manic or hypomanic episode
- Patients experiencing a major depressive episode
- Patients participating in an interventional study involving a drug or medical device or a Category 1 RIPH within 3 months prior to inclusion
- Pregnant, parturient, or breastfeeding woman
Key Trial Info
Start Date :
October 31 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07193914
Start Date
October 31 2025
End Date
March 1 2027
Last Update
January 28 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes
Nîmes, Nîmes, France, 30029